FFA
CRL icon

Farther Finance Advisors’s Charles River Laboratories CRL Stock Holding History

Farther Finance Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Sell
979
-94
-9% -$16.7K ﹤0.01% 2171
2026
Q1 		$188K Buy
1,073
+220
+26% +$40.8K ﹤0.01% 2063
2025
Q4 		$170K Buy
853
+206
+32% +$37.4K ﹤0.01% 2017
2025
Q3 		$101K Buy
647
+32
+5% +$5.08K ﹤0.01% 2039
2025
Q2 		$93.3K Buy
615
+392
+176% +$52.3K ﹤0.01% 1791
2025
Q1 		$32.6K Buy
223
+69
+45% +$11.6K ﹤0.01% 2122
2024
Q4 		$28.4K Buy
154
+17
+12% +$3.27K ﹤0.01% 1925
2024
Q3 		$27K Sell
137
-89
-39% -$18.5K ﹤0.01% 1953
2024
Q2 		$45.9K Buy
226
+117
+107% +$26.5K ﹤0.01% 1455
2024
Q1 		$29.3K Sell
109
-81
-43% -$19.3K ﹤0.01% 1374
2023
Q4 		$44.9K Buy
190
+156
+459% +$30.7K ﹤0.01% 1072
2023
Q3 		$6.66K Sell
34
-22
-39% -$4.52K ﹤0.01% 1418
2023
Q2 		$11.8K Buy
56
+3
+6% +$597 ﹤0.01% 1143
2023
Q1 		$10.7K Buy
53
+16
+43% +$3.63K ﹤0.01% 1090
2022
Q4 		$8.06K Buy
+37
New +$8.08K ﹤0.01% 1015

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Farther Finance Advisors's CRL Position: Q2 2026 in Review

Farther Finance Advisors reduced its Charles River Laboratories (CRL) stake by 8.8% in Q2 2026, selling an estimated $16.7K and leaving 979 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Farther Finance Advisors first reported a position in CRL in Q4 2022 and has held it in 15 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Farther Finance Advisors held 979 shares of Charles River Laboratories worth $222K as of Q2 2026.
  • Farther Finance Advisors sold 94 Charles River Laboratories shares in Q2 2026, an estimated $16.7K.
  • Charles River Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2171 holding.
  • Farther Finance Advisors first reported a position in Charles River Laboratories in Q4 2022 and has held it in 15 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.